DEXCOM INC is 13.5x more valuable than LEMAITRE VASCULAR INC by market capitalization ($28.85 B vs $2.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LMAT | DXCM |
|---|---|---|
| Market cap | $2.13 B | $28.85 B |
| US-listed rank | #2056 | #473 |
| Revenue (latest FY) | $249.60M | $4.66B |
| Net income (latest FY) | $57.70M | $836.30M |
| Net margin | 23.1% | 17.9% |
| P/E (trailing FY) | 37.0 | 34.5 |
| SEC filings | 1,849 | 2,566 |
DEXCOM INC is 13.5x more valuable than LEMAITRE VASCULAR INC by market capitalization ($28.85 B vs $2.13 B).
In their latest fiscal years, LEMAITRE VASCULAR INC reported $249.60M in revenue while DEXCOM INC reported $4.66B.
Full pages: LEMAITRE VASCULAR INC and DEXCOM INC, or browse the full rankings.